Xperi (NASDAQ:XPER) reported quarterly sales of $234.00 million which beat the analyst consensus estimate of $223.76 million by 4.58 percent. This is a 5.28 percent increase over sales of $222.27 million the same period
This was a very challenging year for pot stocks. Year-to-date, AdvisorShares Pure US Cannabis ETF (ARCA:MSOS) dropped 54.01%, AdvisorShares Pure Cannabis ETF (ARCA:YOLO) declined 57.46%, compared to SPDR S&P 500 (ARCA:SPY) which lost 13.61%.